Featured Research

from universities, journals, and other organizations

Use of clot busters for stroke increased from 2005 to 2009, but still low

Date:
June 3, 2011
Source:
American Heart Association
Summary:
The use of a clot-busting drug for stroke increased over a recent five-year period, but it's still low, according to a new study. About 3.4 percent to 3.7 percent of Americans who suffered an ischemic stroke in 2009 received a clot-busting drug compared to 1.1 percent to 1.4 percent in 2005. Researchers believe that the increased use of clot-busting drugs may reduce overall rates of stroke disability and death.

The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 -- but is still low, according to research reported in Stroke: Journal of the American Heart Association.

Clot-busting drugs are known as thrombolytics, and tissue plasminogen activator (tPA) is the only FDA-approved thrombolytic for treating acute ischemic stroke, which is caused by a blood clot in the brain.

Although the study didn't follow patients after hospital discharge, "we believe that the increased treatment rate has the potential to reduce the overall burden of stroke disability and morbidity," said Opeolu Adeoye, M.D., lead author of the study and assistant professor of emergency medicine and neurosurgery at the University of Cincinnati in Ohio.

Using Medicare records and pharmacy billing codes, researchers found 1.1 percent to 1.4 percent of acute ischemic stroke patients received a thrombolytic drug in 2005, and 3.4 percent to 3.7 percent did in 2009.

In a further calculation, the researchers assumed that some or all of the billings for unapproved thrombolytics and/or treating hemorrhagic stroke were billing errors, or represented an ischemic stroke that subsequently developed some bleeding, which occasionally occurs. This upped the use of tPA, Adeoye said, which led to a conservative estimate that 3.4 percent to 5.2 percent -- or 23,800 to 36,000 of the 700,000 Americans who had an ischemic stroke in 2009 -- received tPA.

Treatment with a clot-busting drug is most effective as soon as possible after stroke symptoms begin -- ideally within the first hour, according to American Heart Association/American Stroke Association guidelines. But, doctors can give tPA to some patients up to 4.5 hours after symptoms begin.

Co-authors are Richard Hornung, Ph.D.; Pooja Khatri, M.D.; and Dawn Kleindorfer, M.D.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Journal Reference:

  1. Opeolu Adeoye, Richard Hornung, Pooja Khatri, and Dawn Kleindorfer. Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States: A Doubling of Treatment Rates Over the Course of 5 Years. Stroke, 2011; DOI: 10.1161/STROKEAHA.110.612358

Cite This Page:

American Heart Association. "Use of clot busters for stroke increased from 2005 to 2009, but still low." ScienceDaily. ScienceDaily, 3 June 2011. <www.sciencedaily.com/releases/2011/06/110602162818.htm>.
American Heart Association. (2011, June 3). Use of clot busters for stroke increased from 2005 to 2009, but still low. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/06/110602162818.htm
American Heart Association. "Use of clot busters for stroke increased from 2005 to 2009, but still low." ScienceDaily. www.sciencedaily.com/releases/2011/06/110602162818.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins